MAPT and Alzheimer disease: In AD, YKL-40 is expressed in astrocytes near Aβ plaques (Craig-Schapiro et al., 2010) and correlates positively with tau pathology (Figure 3; Querol-Vilaseca et al., 2017; Janelidze et al., 2018).